DNLI:NASDAQ
Denali Therapeutics Inc
$22.28
arrow_downward
-2.28%(-0.52) 1D
$22.31
arrow_upward
+0.13% (+0.030)bedtimeAfter hours
Closed: Sep 4, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DNLI...
Open
$22.32
High
$22.48
Low
$22.14
Mkt. cap
3.56B
Avg. vol.
1.30M
Volume
799.63K
52-wk high
$27.30
52-wk low
$12.58
EPS
-$2.84
Beta
1.01
Shares outstanding
159.85M
No. of employees
507
Open
$22.32
High
$22.48
Low
$22.14
Mkt. cap
3.56B
Avg. vol.
1.30M
Volume
799.63K
52-wk high
$27.30
52-wk low
$12.58
EPS
-$2.84
Beta
1.01
Shares outstanding
159.85M
No. of employees
507
News stories
From web sources and news partners
Investing.com
·
20 hours ago
Denali Therapeutics director sells $261,928 in stock
Stock Titan
·
1 day ago
Denali Therapeutics (NASDAQ: DNLI) holder to sell shares to cover tax on stock units
About Denali Therapeutics Inc
CEO-
Employees507
Founded2013
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitedenalitherapeutics.com